BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

231 related articles for article (PubMed ID: 28512015)

  • 21. Expression and promotor hypermethylation of miR-34a in the various histological subtypes of ovarian cancer.
    Schmid G; Notaro S; Reimer D; Abdel-Azim S; Duggan-Peer M; Holly J; Fiegl H; Rössler J; Wiedemair A; Concin N; Altevogt P; Marth C; Zeimet AG
    BMC Cancer; 2016 Feb; 16():102. PubMed ID: 26879132
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Genome structure-based screening identified epigenetically silenced microRNA associated with invasiveness in non-small-cell lung cancer.
    Watanabe K; Emoto N; Hamano E; Sunohara M; Kawakami M; Kage H; Kitano K; Nakajima J; Goto A; Fukayama M; Nagase T; Yatomi Y; Ohishi N; Takai D
    Int J Cancer; 2012 Jun; 130(11):2580-90. PubMed ID: 21702040
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Methylation Status of miR-34a and miR-126 in Non-Small Cell Lung Cancer (NSCLC) Tumor Tissues.
    Mehrzad N; Zamani MS; Rahimi A; Shamaei M; Karimipoor M
    Iran Biomed J; 2024 Jan; 28(1):53-8. PubMed ID: 38445462
    [TBL] [Abstract][Full Text] [Related]  

  • 24. CpG island methylation status of miRNAs in esophageal squamous cell carcinoma.
    Chen X; Hu H; Guan X; Xiong G; Wang Y; Wang K; Li J; Xu X; Yang K; Bai Y
    Int J Cancer; 2012 Apr; 130(7):1607-13. PubMed ID: 21547903
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Unique microRNAs in lung adenocarcinoma groups according to major TKI sensitive EGFR mutation status.
    Pak MG; Lee CH; Lee WJ; Shin DH; Roh MS
    Diagn Pathol; 2015 Jul; 10():99. PubMed ID: 26170125
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The expression of microRNA-34a is inversely correlated with c-MET and CDK6 and has a prognostic significance in lung adenocarcinoma patients.
    Hong JH; Roh KS; Suh SS; Lee S; Sung SW; Park JK; Byun JH; Kang JH
    Tumour Biol; 2015 Dec; 36(12):9327-37. PubMed ID: 26104764
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Methylation-associated silencing of microRNA-34b/c in gastric cancer and its involvement in an epigenetic field defect.
    Suzuki H; Yamamoto E; Nojima M; Kai M; Yamano HO; Yoshikawa K; Kimura T; Kudo T; Harada E; Sugai T; Takamaru H; Niinuma T; Maruyama R; Yamamoto H; Tokino T; Imai K; Toyota M; Shinomura Y
    Carcinogenesis; 2010 Dec; 31(12):2066-73. PubMed ID: 20924086
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Expression and Methylation Pattern of hsa-miR-34 Family in Sperm Samples of Infertile Men.
    Momeni A; Najafipour R; Hamta A; Jahani S; Moghbelinejad S
    Reprod Sci; 2020 Jan; 27(1):301-308. PubMed ID: 32046388
    [TBL] [Abstract][Full Text] [Related]  

  • 29. miR-34a as a prognostic marker of relapse in surgically resected non-small-cell lung cancer.
    Gallardo E; Navarro A; Viñolas N; Marrades RM; Diaz T; Gel B; Quera A; Bandres E; Garcia-Foncillas J; Ramirez J; Monzo M
    Carcinogenesis; 2009 Nov; 30(11):1903-9. PubMed ID: 19736307
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Detection of miR-34a and miR-34b/c in stool sample as potential screening biomarkers for noninvasive diagnosis of colorectal cancer.
    Wu XD; Song YC; Cao PL; Zhang H; Guo Q; Yan R; Diao DM; Cheng Y; Dang CX
    Med Oncol; 2014 Apr; 31(4):894. PubMed ID: 24573638
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Promoter hypermethylation of miR-34a contributes to the risk, progression, metastasis and poor survival of laryngeal squamous cell carcinoma.
    Shen Z; Zhou C; Li J; Ye D; Li Q; Wang J; Cui X; Chen X; Bao T; Duan S
    Gene; 2016 Nov; 593(2):272-6. PubMed ID: 27450916
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Silencing of miR-137 by aberrant promoter hypermethylation in surgically resected lung cancer.
    Kang N; Choi SY; Kim YK; Yoo IeR; Han DH; Lee DS; Kim YS; Hong SH; Kang JH; Lee KY; Park JK; Sung SW; Park MS; Yim HW; Kim SJ; Park JY
    Lung Cancer; 2015 Aug; 89(2):99-103. PubMed ID: 26101014
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Distinct roles of miR-34 family members on suppression of lung squamous cell carcinoma.
    Sun D; Wu Y; Zhang S; Han Y; Shen J; Zheng W; Wei L; Liu Y; Ren L; Gu Z; Liu Y; Liu S; Ding C
    Biomed Pharmacother; 2021 Oct; 142():111967. PubMed ID: 34467896
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Expression and significance of miR-34 with PI3K, AKT and mTOR proteins in colorectal adenocarcinoma tissues.
    Li Y; Jin L; Rong W; Meng F; Wang X; Wang S; Yu X
    Cell Mol Biol (Noisy-le-grand); 2022 Sep; 68(9):57-62. PubMed ID: 36905274
    [TBL] [Abstract][Full Text] [Related]  

  • 35. miR-3941: A novel microRNA that controls IGBP1 expression and is associated with malignant progression of lung adenocarcinoma.
    Sato T; Shiba-Ishii A; Kim Y; Dai T; Husni RE; Hong J; Kano J; Sakashita S; Iijima T; Noguchi M
    Cancer Sci; 2017 Mar; 108(3):536-542. PubMed ID: 28012229
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Expression and significance of microRNAs in the p53 pathway in ovarian cancer cells and serous ovarian cancer tissues].
    Zhang Q; He XJ; Ma LP; Li N; Yang J; Cheng YX; Cui H
    Zhonghua Zhong Liu Za Zhi; 2011 Dec; 33(12):885-90. PubMed ID: 22340095
    [TBL] [Abstract][Full Text] [Related]  

  • 37. MicroRNA-34b and MicroRNA-34c are targets of p53 and cooperate in control of cell proliferation and adhesion-independent growth.
    Corney DC; Flesken-Nikitin A; Godwin AK; Wang W; Nikitin AY
    Cancer Res; 2007 Sep; 67(18):8433-8. PubMed ID: 17823410
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prognostic impact of miR-34b/c DNA methylation, gene expression, and promoter polymorphism in HPV-negative oral squamous cell carcinomas.
    Supic G; Stefik D; Ivkovic N; Sami A; Zeljic K; Jovic S; Kozomara R; Vojvodic D; Stosic S
    Sci Rep; 2022 Jan; 12(1):1296. PubMed ID: 35079080
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Expression and Promoter CpG Island Methylation Status of miR-34b in Leukemia Cell Lines and Their Clinical Significance].
    Guo JX; Zhou YH; Guan RT; Pan JX; Zhang XY; Zhong JF
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2015 Oct; 23(5):1235-9. PubMed ID: 26524015
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Curcumin activates a ROS/KEAP1/NRF2/miR-34a/b/c cascade to suppress colorectal cancer metastasis.
    Liu C; Rokavec M; Huang Z; Hermeking H
    Cell Death Differ; 2023 Jul; 30(7):1771-1785. PubMed ID: 37210578
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.